SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615774-15-003094
Filing Date
2015-11-03
Accepted
2015-11-03 16:33:28
Documents
17
Period of Report
2015-11-03
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K s102104_8k.htm 8-K 16918
2 EXHIBIT 99.1 s102104_991.htm EX-99.1 17622
3 GRAPHIC image_016.jpg GRAPHIC 261073
4 GRAPHIC image_017.jpg GRAPHIC 191231
5 GRAPHIC image_018.jpg GRAPHIC 284674
6 GRAPHIC image_019.jpg GRAPHIC 294695
7 GRAPHIC image_020.jpg GRAPHIC 235858
8 GRAPHIC image_021.jpg GRAPHIC 269101
9 GRAPHIC image_022.jpg GRAPHIC 312157
10 GRAPHIC image_023.jpg GRAPHIC 268693
11 GRAPHIC image_024.jpg GRAPHIC 245579
12 GRAPHIC image_025.jpg GRAPHIC 179657
13 GRAPHIC image_026.jpg GRAPHIC 248159
14 GRAPHIC image_027.jpg GRAPHIC 222449
15 GRAPHIC image_028.jpg GRAPHIC 253393
16 GRAPHIC image_029.jpg GRAPHIC 318651
17 GRAPHIC image_030.jpg GRAPHIC 314098
  Complete submission text file 0001615774-15-003094.txt   5408525
Mailing Address 200 CAMBRIDGEPARK DRIVE, SUITE 2000 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGEPARK DRIVE, SUITE 2000 CAMBRIDGE MA 02140 (617) 674-1865
Enumeral Biomedical Holdings, Inc. (Filer) CIK: 0001561551 (see all company filings)

IRS No.: 990376434 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55415 | Film No.: 151194139
SIC: 2834 Pharmaceutical Preparations